Edition:
Deutschland

Astellas Pharma Inc (4503.T)

4503.T on Tokyo Stock Exchange

1,530JPY
20 Sep 2019
Change (% chg)

¥8 (+0.53%)
Prev Close
¥1,522
Open
¥1,526
Day's High
¥1,560
Day's Low
¥1,523
Volume
8,797,700
Avg. Vol
5,653,710
52-wk High
¥2,026
52-wk Low
¥1,356

About

Astellas Pharma Inc. is a Japan-based company mainly engaged in the research, development, manufacture and sales of pharmaceutical products. The Company is involved in the manufacture and sale of pharmaceutical products in Japan, the United States, Europe, China, Korea, Taiwan and other markets through its subsidiaries. Its main... (more)

Buy/Sell

Sell Hold Buy
2.30 Mean rating from 10 analysts

Overall

Beta: 0.69
Market Cap(Mil.): ¥2,877,622.00
Shares Outstanding(Mil.): 1,888.82
Dividend: 20.00
Yield (%): 2.49

Japanese share slip as U.S., China impose more tariffs

TOKYO, Sept 2 Japanese shares slipped on Monday after the United States and China imposed more tariffs on each other's goods, escalating a dispute that is increasingly weighing on export-reliant Asia and disrupting global trade.

Japanese shares dip after activation of U.S-China tariffs

TOKYO, Sept 2 Japanese shares dipped on Monday as the weekend activation by the United States and China of tariffs on some of each other's goods deepened the ongoing trade war between the pair.

Nikkei retreats as investors nervous before Trump-Xi meeting

TOKYO, June 28 Tokyo stocks fell on Friday as investors turned cautious ahead of much awaited talks between U.S. and Chinese leaders on the sidelines of the G20 summit in Japan, with cyclical shares retreating before the weekend.

Nikkei drops as investors cautiously await G20; cyclical stocks fall

TOKYO, June 28 Japan's Nikkei fell on Friday as investors turned cautious ahead of much awaited talks between U.S. and Chinese leaders at the G20 summit, with cyclical shares sliding on profit-taking before the weekend.

Nikkei edges up in choppy trade; weak yen supports exporters

TOKYO, June 11 Japan's Nikkei ended higher in choppy trade on Tuesday as cyclical stocks, inclding exporters, gained on the back of a weaker yen, while defensive firms underperformed.

Nikkei edges higher in choppy trade; weak yen supports exporters

TOKYO, June 11 Japan's Nikkei edged higher in choppy trade on Tuesday morning as investors took profits from sharp gains on the previous day, while a weaker yen underpinned cyclical stocks such as exporters.

UPDATE 1-Seattle Genetics, Astellas drug rapidly shrinks tumors in bladder cancer study

June 3 An experimental drug developed by Seattle Genetics Inc and Astellas Pharma Inc led to significant, rapid tumor shrinkage in patients with advanced bladder cancer who had been previously treated with immunotherapy and chemotherapy in a midstage trial, according to data presented on Monday.

CORRECTED-Seattle Genetics, Astellas drug shows rapid tumor shrinkage in advanced bladder cancer study

June 3 An experimental drug developed by Seattle Genetics Inc and Astellas Pharma Inc led to significant, rapid tumor shrinkage in patients with advanced bladder cancer who had been previously treated with immunotherapy and chemotherapy in a midstage trial, according to data presented on Monday.

Nikkei hits 3-1/2-month low as hopes of early resolution to U.S.-China standoff fade

TOKYO, May 30 Japan's Nikkei share average closed at a 3-1/2-month low on Thursday, on growing anxiety the trade dispute between the United States and China will be prolonged and damaging to the economy.

Märkte

  • U.S.
  • Europa
  • Asien
  • Branchen

Branchenüberblick

Energie -0.08%
Rohstoffe -0.55%
Industrie -0.61%
Konjunktur abhängige Waren & Dienstleistungen -0.28%
Konjunktur unabhängige Waren & Dienstleistungen -0.19%
Finanzindustrie +0.60%
Pharma -0.87%
Technologie +0.65%
Telekommunikation +0.19%